Company intelligence / Profile preview

MaxifyMed

Ownership: Private
Development stage: Commercial

Overview

MaxifyMed is an active healthcare consulting and commercialization firm specializing in helping smaller, innovative medical companies bring their products and platforms to market. The company provides hands-on tactical support for product launches, focusing on limited market releases and strategic early adopter engagement. Its advisory team includes experienced executives from hospitals, clinics, payers, startups, Fortune 500 commercial leaders, physicians/scientists, and former FDA employees. There are no clinical results as it does not develop its own therapies.

Industry: Consulting

Partnerships

Collaborates with smaller medtech innovators as clients but no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on MaxifyMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MaxifyMed.

Explore the full profile